Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Moody’s warns of continued supply chain and labor problems for medtech

February 8, 2022 By Jim Hammerand

Amazon COVID-19 diagnostics lab in Hebron, Kentucky supply chain

As the latest COVID-19 wave recedes, testing demand will likely follow. [Image courtesy of Amazon]

Moody’s warned investors that supply chain disruptions and healthcare worker shortages will continue to pressure medical product and device companies in 2022.

The good news from the Moody’s Healthcare Quarterly report? The supply chain issues are manageable, with Moody’s estimating that transportation costs average less than 3% of revenue for most large, rated device companies, which won’t eat up too much of those companies’ 20% profit margins.

The bad news: Healthcare labor shortages show no sign of improvement, with nearly a quarter of U.S. hospitals reporting critical staffing shortages in early January due to the omicron COVID-19 variant, according to the U.S. Department of Health and Human Services.

“Large numbers of nurses and other skilled workers will continue to leave the workforce as a result of fatigue, caregiving responsibilities and the opportunity to earn higher wages in other fields. … The shortage is curtailing elective surgeries in hospitals across the country,” Moody’s said in the report. “If the healthcare system globally remains capacity constrained, it would have a material impact on procedure volumes, and therefore, some medical product and device companies.”

More good news: The omicron wave seems to be receding, and hospital capacity could open back up just as it did after the delta wave, relieving the burden on healthcare workers and bringing in patients who delayed elective procedures.

“Volumes and industry revenues had largely returned prior to Omicron, and in some cases, exceeded pre-pandemic levels. We expect industry revenues to further expand in 2022, driven by pent-up demand for deferred procedures,” the report said.

Because we’ve been through this before, we know there’s a big “but” coming: “However, there is a meaningful downside risk to our view if the current, or a future, variant remains widespread,” Moody’s said in the report.

Edwards Lifesciences, Zimmer Biomet, Cardiovascular Systems and Boston scientific are among the companies that have recently cited continued sales impacts from the omicron variant and associated labor shortages.

If ever-increasing vaccination rates can push down cases and the spread of new variants, COVID-19 testing revenue for diagnostics firms like Abbott and Hologic will likely decrease.

The upside for those companies is that acceptance of at-home testing seems to be increasing, and “such tests, whether for the coronavirus or other types of diseases, like the flu, will likely become a more permanent feature of the healthcare landscape,” the report said.

What does all this mean for mergers and acquisitions?

Moody’s expects activity “will remain robust in 2022 as most medical device companies have seen their credit metrics largely recover since the onset of the pandemic.”

Most of the transactions will be valued at or below $1 billion as they have historically, and Moody’s expects fewer mega-deals like Baxter’s $12.5 billion purchase of Hill-Rom Holdings.

Moody’s cited BD’s appetite for moderately priced tuck-in deals and said “acquirers will mostly look to buy companies that support or enhance their key product franchises.”

That’s what Medtronic CFO Kathleen Parkhill said when she discussed the M&A strategy of medtech’s largest player with Medical Design & Outsourcing in the second half of last year.

You may also like:

  • CMR Surgical's Versius system console
    Surgical robotics developer leads device makers in top healthcare VC…
  • A photo of former Medtronic CFO Karen Parkhill
    Medtronic’s M&A strategy explained by CFO Karen Parkhill

  • Healthcare venture funding boomed in 2021; expect a slowdown in…

  • An even larger medtech supply chain shock looms beyond the…

Related Articles Read More >

Min-Vasive Medtech: Live interviews and audience Q&As with minimally invasive engineers from Edwards Lifesciences, Jupiter Endo and Compremium
PrecisionX Group buys Hudson Technologies
PSN Labs expands ISO 13485 certification to design and development
DIVA Labs announces imaging product developments
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe